• search
In vitro ADME Services In vitro ADME Services

In vitro ADME Services

In vitro ADME assays catering to every stage of drug discovery; standalone studies and customized assays.

We have more than 16 years of experience in ADME drug discovey services. We have validated ADME assays in place, amenable to customized study design as per customer requirement. Our expert team of scientists cater to the ADME requirements with unparalleled troubleshooting abilities. We have experience in handling small molecules, therapeutic peptides and complex molecules.

Speak to our experts

Physiochemical Properties

Solubility and chemical stability at different pH, SIF and SGF

Solubility: Kinetic, thermodynamic, HT Log D

Permeability

Caco-2 Bi-directional permeability, Efflux ratio MDCK, MDCK-LE, MDCK-MDR1, MDCK-BCRP permeability PAMPA

Distribution

Plasma Protein, in vitro Tissue binding

Blood to plasma partition

Brain to plasma partition

Metabolism

Microsomal Clearance, S9, Phase I/Phase II, Hepatocyte Clearance

Plasma/ Whole Blood Stability CYP Phenotyping

Drug-Drug Interactions

CYP Inhibition, CYP TDI, kobs

CYP Induction

P-gp and BCRP Inhibition & Substrate Identification

Why Aurigene In vitro ADME Services?

Quick turnaround time: In vitro Assays: 5 working days

High throughput (96-well plate) assays

Unidirectional and bidirectional permeability

Highly-experienced and expert team of scientists

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

rightCaptcha

Neoantigen Specific T cells For Cancer Immunotherapy

Neoantigen Specific T cells For Cancer Immunotherapy

An effective anti-tumor immune response in human is marked by presence of T cells reactive against neoantigens. Neoantigens are HLA-bound unique peptides arise from tumor-specific somatic mutations. Neoantigens are highly immunogenic because they are not present in normal tissues and hence bypass central thymic tolerance. The success of immune checkpoint blockade...

Read More

Accelerating Drug Discovery Through Innovative Partnerships

Genomics plays a vital role in identifying which gene is associated with a specific disease. A gene called CNOT1 is for example known for it's effect on brain development and for impairing memory and learning. Despite the great promise genomics provides in understanding the disease, genes are not the best drug targets....

Read More

Physiochemical Characterization Services

Backed by our strong chemistry, we enable “Finger-print” protein structure and functional characterization for proteins from naked proteins to hyperglycosylated or derivatized proteins. ...

Read More

Developing a methodology for In situ perfusion based combined tissue distribution and toxicity evaluation study

Challenges: Several repeated in house validation studies were performed to optimize the suitable perfusate (liquid medium intended to pass through the heart), perfusate volume and perfusion rate to ensure complete perfusion of animal subjects (parameters weren’t adjustable) Challenges were encountered in adjusting the perfusion volume and rate vis-à-vis ensuri...

Read More

Synthesis of 2-hydroxy-3-alkyl-2-phenyl-2,3- dihydroquinazolin-4(1H)-one via molybdenum hexacarbonyl mediated CO gas- and ligand free carbonylative reactions

2016

Carbon monoxide gas and ligand-free conditions were developed for the synthesis of 2-hydroxy-3-alkyl-2-phenyl-2,3-dihydroquinazolin4(1H)-one via catalytic carbonylation with molybdenum hexacarbonyl as an efficient carbonylating agent for the three-component reaction of isatoic anhydride, amine, iodobenzene. Mo(CO)6 is a solid carbon monoxide source. The quinazoli...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack